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The rationale for ambulatory extracorporeal membraneoxygenation (ECMO) is simple:
(1) Upright patients who are ambulatory and socially
interactive provide the most effective vehicle for clinical
recovery or subsequent bridge to transplant.(2) No lung disease or pulmonary injury beneﬁts from
paralysis, sedation, and intubation with nonphysiolog-
ical positive pressure ventilation.The objective data for these simple observations are well
established and include the traditional morbidities of
ventilator-associated pneumonias, barotrauma as a conse-
quence of positive pressure ventilation, the requirements of
sedation and paralytics to facilitate permissive hypercapnea
as a strategy to limit barotrauma, and the profound
deconditioning of both respiratory and skeletal muscle
because of “ventilated, bed-bound” care.
Although the use of ambulatory ECMO is an extension of
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common to ambulatory ECMO are designed to facilitate an
extubated and ambulatory patient. It is neither new nor novel
and is analogous to the ventricular assist technologies common
to patients with acute cardiogenic shock and congestive heart
failure. Early deployment of technology to resuscitate the sick
patient rather than reanimate the moribund is always the goal
of extracorporeal support technologies. Nonetheless, the
“peripheral” hybrid technologies of venovenoarterial ECMO
and the application of “central” cannulation with “oxyRVADs”
(right ventricular assist device with an in-line oxygenator) can
salvage the sickest patients with medically refractory end-stage
lung disease to ambulatory status.
The following description of cannulation strategies is “goal
directed” and “case speciﬁc.” Each is designed to support
ambulatory patients with distinct clinical needs. Hyper-
capnea, hypoxia, or cardiopulmonary collapse as a con-
sequence of cor pulmonale require different strategies of
initial ECMO deployment. The described techniques are not
exhaustive. Any cannulation strategy that delivers an
adequate cardiac output with adequate gas exchange in an
ambulatory patient is effective. Clinical need determines
cannulation strategy. “Thought algorithms” regarding the
application of ECMO—why are you doing this and what do
you hope to accomplish—and the deployment of ECMO—
how do we do it and when do we try—are useful in
establishing conceptual ground rules for device deployment.129
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Figure 1 Percutaneous dual-lumen cannulation (DLC) for venovenous (VV) ECMO. The Avalon Elite Bi-Caval Dual Lumen Catheter (Maquet)
is positional and requires interventional deployment with transesophageal echocardiography or ﬂuoroscopy or both. Distinct venous inﬂow
from both IVC and SVC and directional outﬂow across the tricuspid valve limit mixing of preoxygenator and postoxygenator blood and
improve efﬁcacy to facilitate ambulation. The cannula can be deployed via internal jugular or left subclavian veins. In patients with
suprasystemic pulmonary artery pressures, combined DLC VV ECMO and atrial septostomy can provide hemodynamic support of the
ambulatory patient without central cannulation.2 We routinely use the 27-Fr dual-lumen venovenous cannula (adult cannula are 31 cm in
length and vary in diameter from 20-31 Fr). Pediatric cannula (13-19 Fr) can provide effective extracorporeal carbon dioxide removal as an
integrated tool with mechanical ventilation. IVC ¼ inferior vena cava, SVC ¼ superior vena cava.
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Figure 2 (A) “Hybrid” DLC VV ECMO with right axillary arterial return (venovenoarterial, VVA ECMO). The right axillary artery is exposed
through a transverse incision. (B) An 8-mm Hemashield vascular graft (MAQUET Cardiovascular LLC, NJ) is sewn end to side to the axillary
artery with a taper so as to orient the blood path retrograde into the innominate artery. No surgical bleeding is tolerated. The graft is tunneled
subcutaneously to the skin. A 24 Fr RMI Edwards (Edwards Lifesciences LLC, CA) or Sarns Softﬂow 7-mm cannula (Terumo Cardiovascular
Systems Corporation, MI) is placed within the Dacron graft and the tip of the inﬂow cannula is secured with ligatures 2 cm proximal to the
axillary anastomosis . The skin is closed to prevent infection and an upper extremity sling can prevent bleeding complications associated with
increased patient mobility. DLC ¼ dual-lumen cannulation; VV ¼ venovenous.
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Figure 3 “Partial bypass” walking ECMO. Venous drainage from percutaneous right IJ access via a 20 Fr EOPA CAP arterial cannula
(Medtronic). Postoxygenator arterial inﬂow is via the right axillary approach as described in Figure 2. Venous drainage limits full
hemodynamic support but patients with mixed cardiopulmonary disease can effectively ambulate with 3-4 L/min of ﬂow.
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Figure 4 “Pulmonary bypass.” A 10-mm Dacron outﬂow graft (Abiomed AB5000 cannula) is sewn to the main pulmonary artery distal to the
pulmonary valve. An angled 28 Fr metal-tip cannula is placed within the left atrial appendage. The surgical approach is determined by clinical
intent: median sternotomy for subsequent combined heart and lung transplant or “clamshell” anterior thoracotomies for subsequent bilateral
lung transplant. Patients with acute cor pulmonale are initially stabilized with femoral VA ECMO and transitioned to VVA hybrid ECMO or VV
ECMO with atrial septostomy. Central cannulation is reserved for patients inadequately supported by the percutaneous approach and actively
listed for solid organ transplant. VA ¼ venoarterial; VVA ¼ venovenoarterial; VV ¼ venovenous.
In patients with suprasystemic pulmonary artery pressures and preserved RV function native right-sided cardiac output can deliver up to
3 L/min of ﬂow across a Quadrox oxygenator in the absence of a centrifugal pump (pumpless extracorporeal lung assist; PECLA). This is our
preferred approach in patients with cor pulmonale being bridged to transplant. If ﬂows are insufﬁcient, a centrifugal pump can be spliced into
the circuit to provide adequate LV preload. RV ¼ right ventricle; LV ¼ left ventricle.
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Figure 5 The “oxyRVAD.” In patients with compromised RV function due to end-stage pulmonary disease, the “oxyRVAD” conﬁguration
provides full hemodynamic support with gas exchange to a “normal” left ventricle. A 28 Fr angled metal-tip catheter within the right atrium
provides venous drainage, a 10-mm Dacron outﬂow graft (Abiomed AB5000 cannula) sewn with 4.0 prolene to the main pulmonary artery
can deliver up to 5 L/min of right-sided cardiac output. RV ¼ right ventricle.
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Figure 6 “Walking CPB.” In patients awaiting combined heart-lung transplant “walking cardiopulmonary bypass” can provide adequate
hemodynamic support for ambulation. A 31-Fr catheter in the right atrium is required for venous drainage, a 15-mm Dacron outﬂow graft
(Thoratec PVAD cannula) is sewn to the ascending aorta (4.0 prolene) for postoxygenator blood return. CPB, cardiopulmonary bypass.
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Figure 7. Management algorithm for ambulatory ECMO.
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Although ECMO deployment is not technically difﬁcult,
many patients require multiple revisions of cannulation
strategy to transition from mechanical ventilation to
ambulation. A patient management algorithm is outlined
here.1 In brief, appropriate patients are stabilized on femoral
venoarterial ECMO (25 Fr venous and 17 Fr aortic). All
patients undergo open tracheostomy at the time of ECMO
deployment. All sedation and vasopressor support is weaned
and patients with signiﬁcant neurologic deﬁcits are removed
from ECMO support. The “awake” patient without
echocardiography (ECHO) criteria for compromised ven-
tricular function undergoes “PECLA triage” (pumpless
extracorporeal lung assist) with removal of the centrifugal
pump and antegrade ﬂow from the femoral arterial cannula
to the right atrium via a long venous cannula using native
cardiac output. Patients with stable hemodynamics are
switched to double-lumen venovenous ECMO (Fig. 1) for
ambulation. Patients with any hemodynamic concerns
are deployed on hybrid venovenoarterial ECMO using the
axillary approach (Fig. 2). Patients with moderate to severe
pulmonary hypertension have double-lumen venovenousECMO deployed with an associated atrial septostomy to
preload the underﬁlled left ventricle with membrane
oxygenated blood (Figs. 3 and 4). Patients with RV failure
due to end-stage lung disease undergo central cannulation
with an “oxyRVAD” conﬁguration as an ambulatory bridge
to transplant (Figs. 5 and 6). Patients with mixed end-stage
heart and lung disease are placed on “walking bypass”
(Fig. 7).
Ambulatory ECMO is labor intensive, and program
development requires both a signiﬁcant change in critical
care culture and a signiﬁcant investment in institutional
resources. Institutional culture is the most signiﬁcant
predictor of effective ambulatory ECMO utilization and
program sustainability.References
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